![](/img/cover-not-exists.png)
A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Yau, T. C., Lencioni, R., Sukeepaisarnjaroen, W., Chao, Y., Yen, C.-J., Lausoontornsiri, W., Chen, P.-J., Sanpajit, T., Camp, A., Cox, D. S., Gagnon, R. C., Liu, Y., Raffensperger, K. E., Kulkarni, D.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-1789
Date:
November, 2016
File:
PDF, 827 KB
english, 2016